Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8598453rdf:typepubmed:Citationlld:pubmed
pubmed-article:8598453lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C0245662lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1539477lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1705955lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:8598453lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:8598453pubmed:issue1lld:pubmed
pubmed-article:8598453pubmed:dateCreated1996-4-23lld:pubmed
pubmed-article:8598453pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:abstractTextFAS/Apo-1 (CD95) is an apoptosis-signaling cell surface receptor belonging to the TNF receptor family. Tumor cells resistant to Fas-mediated apoptosis have been described, but to date, the mechanisms responsible for this resistance are not well understood. We found that a series of apoptosis-resistant clones from human HUT78 lymphoma cells express a splicing variant coding for a truncated Fas molecule that lacks the intracellular death-signaling domain. The mutation responsible for the FasExo8Del expression was identified as a deletion-insertion in the intron 7/exon 8 region of the Fas gene. Moreover this mutation affects the phenotype in a dominant negative fashion, i.e., even in the presence of the normal receptor.lld:pubmed
pubmed-article:8598453pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:languageenglld:pubmed
pubmed-article:8598453pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8598453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8598453pubmed:statusMEDLINElld:pubmed
pubmed-article:8598453pubmed:monthJanlld:pubmed
pubmed-article:8598453pubmed:issn0022-1767lld:pubmed
pubmed-article:8598453pubmed:authorpubmed-author:TestaJJlld:pubmed
pubmed-article:8598453pubmed:authorpubmed-author:De MariaRRlld:pubmed
pubmed-article:8598453pubmed:authorpubmed-author:CascinoIIlld:pubmed
pubmed-article:8598453pubmed:authorpubmed-author:RubertiGGlld:pubmed
pubmed-article:8598453pubmed:authorpubmed-author:PapoffGGlld:pubmed
pubmed-article:8598453pubmed:issnTypePrintlld:pubmed
pubmed-article:8598453pubmed:day1lld:pubmed
pubmed-article:8598453pubmed:volume156lld:pubmed
pubmed-article:8598453pubmed:ownerNLMlld:pubmed
pubmed-article:8598453pubmed:authorsCompleteYlld:pubmed
pubmed-article:8598453pubmed:pagination13-7lld:pubmed
pubmed-article:8598453pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:meshHeadingpubmed-meshheading:8598453-...lld:pubmed
pubmed-article:8598453pubmed:year1996lld:pubmed
pubmed-article:8598453pubmed:articleTitleFas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.lld:pubmed
pubmed-article:8598453pubmed:affiliationDepartment of Immunobiology, National Research Council, Rome, Italy.lld:pubmed
pubmed-article:8598453pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8598453pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8598453pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:355entrezgene:pubmedpubmed-article:8598453lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8598453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8598453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8598453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8598453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8598453lld:pubmed